Cancer

A new study finds that infections are responsible for roughly one in eight cancer cases around the world, underscoring the role of viruses and bacteria such as HPV and hepatitis in triggering disease. The findings are drawing attention to vaccination, screening and treatment of infections as practical tools for cancer prevention globally.

Roughly one in eight cancer cases globally is attributed to infectious pathogens, chiefly human papillomavirus, Helicobacter pylori, and hepatitis B and C viruses. The figure is drawing attention because many of these cancers are preventable through vaccination, such as HPV shots, along with screening and antiviral or antimicrobial treatment. Health advocates are using the estimate to argue for wider vaccine coverage and earlier detection programs.

An essay cataloguing the many everyday items and habits that have, at one time or another, been labelled as causing cancer is drawing attention. The piece reflects on how shifting and seemingly contradictory health warnings can erode public trust in scientific guidance, prompting readers to share their own examples of claims that did not hold up.

South Africa's Proteas took on Australia in the second one-day international, played as the traditional Pink Day fixture at the Wanderers in support of breast cancer awareness. Highlights of the match are drawing wide attention, with fans discussing the key moments and the state of the series between the two sides.

Researchers at the University of Arizona report that sex chromosomes, not just sex hormones, play a major role in how the body handles cancer, heart disease and lifespan. The findings suggest the X and Y chromosomes influence disease risk and ageing in ways that go beyond hormonal differences, which could reshape how scientists study sex-based differences in medicine.

A growing list of people associated with October 4 in any year now includes Henrietta Lacks, the Black woman whose cancer cells were taken without her consent in 1951 and became foundational to modern medical research. The listing places her alongside other notable figures tied to the date, and is being shared in discussions of Black history and representation in film and television.

Hometown News Treasure Coast highlights an approach to cancer care that treats the whole person, not just the disease. The report points to attention on nutrition, emotional wellbeing and overall quality of life alongside medical treatment for cancer patients, reflecting a broader shift toward holistic supportive care in oncology.

A question circulating among economics and health commentators asks whether Costco causes cancer. The framing is analytical rather than a documented health warning, examining whether patterns in Costco's business or its shoppers could plausibly be linked to cancer rates. No evidence of an established causal finding is provided, and readers are treating it as a discussion point on correlation versus causation.

Bayer is confronting a new trial in Missouri over claims that its Roundup weedkiller caused cancer, even as the company awaits a judge's decision on a proposed $7.25 billion settlement intended to resolve thousands of similar lawsuits. The outcome of both the trial and the settlement ruling could shape Bayer's ongoing legal exposure over glyphosate products.

A scientific debate is under way over the role of a truncated ALK transcript in solid tumours. One view treats it as a promising biomarker for diagnosing or stratifying cancers, while sceptics question whether it has real biological function or is largely overhyped. The discussion reflects a wider push in oncology to validate novel transcript-based markers before they enter clinical practice.

Researchers have developed a deep learning tool that analyzes the regulatory code of leukemia cells to predict patient risk. By reading how gene regulation differs in patients, the model aims to forecast disease severity and guide treatment decisions. The approach highlights how artificial intelligence is increasingly being applied to cancer genomics and precision medicine.

The Hindu's Health Wrap Episode 53 examines three pressing health issues: the rising cost of cancer medicines, the growing misuse of medications, and the ongoing dengue burden. The episode pulls together recent reporting on affordability of treatment, irrational use of drugs, and efforts to control mosquito-borne dengue outbreaks, offering a consolidated briefing for readers following India's public health debates.

Health experts are revisiting the question of whether a single alcoholic drink a day can raise a person's cancer risk. The topic, highlighted by Hartford HealthCare, is part of a broader conversation about the health effects of light to moderate drinking, as research continues to examine links between alcohol consumption and several cancers.

Sylvester Comprehensive Cancer Center is raising the question of who is helping determine how artificial intelligence is implemented in clinical trial operations. The item, highlighted by Oncodaily, points to an ongoing discussion in the oncology research community about the role clinicians, coordinators and sponsors play in adopting AI tools for running trials.

New research indicates that the loss of a single gene can allow melanoma to evade targeted cancer therapies. The finding helps explain why patients often relapse after initially responding to drugs designed to attack specific melanoma mutations. Scientists say understanding this resistance mechanism could guide new treatment combinations and improve outcomes for skin cancer patients.

Iovance Biotherapeutics, the biotechnology company behind the cell therapy Amtagvi, is seeing its IOVA shares tracked closely by investors on finance platforms. Traders are following the stock price, quotes and recent news flow as the company works to commercialise its tumour-infiltrating lymphocyte therapies. No specific earnings announcement or clinical update is confirmed, leaving the exact catalyst for interest unclear.

Verastem, Inc. (NASDAQ: VSTM), a biotechnology company focused on cancer treatments, is seeing increased interest in its stock price and trading activity. Investors are checking quotes, news updates and historical performance data as they weigh the company's outlook. No specific corporate announcement has been cited in connection with the attention.

Barry Manilow, the 82-year-old singer who recently announced a cancer diagnosis, spoke on Good Morning America about losing his voice as he prepares for his upcoming tour. The interview covered how the health setback is affecting his ability to perform and his plans for the tour dates, prompting widespread concern and support from fans.